SETDB1 Methylates MCT1 Promoting Tumor Progression by Enhancing the Lactate Shuttle

Area of Science:

• Molecular Biology
• Cancer Research
• Biochemistry

Background:

• Monocarboxylate transporter 1 (MCT1) is crucial for lactate transport and tumor metabolism.
• Post-transcriptional regulation of MCT1 remains incompletely understood.
• Understanding MCT1 regulation is vital for targeting cancer cell metabolism.

Purpose of the Study:

• To identify novel post-translational modifications regulating MCT1 stability and function.
• To investigate the role of SETDB1 in MCT1 regulation.
• To explore the implications of MCT1 modification in colorectal cancer (CRC) progression.

Main Methods:

• In vitro and in vivo assays to study SETDB1-MCT1 interaction and methylation.
• Analysis of MCT1 interaction with Tollip and subsequent autophagic degradation.
• Assessment of MCT1 K473 tri-methylation effects on tumor glycolysis and macrophage polarization in CRC models.
• Clinical correlation studies of MCT1 K473 tri-methylation with CRC progression and survival.

Main Results:

• SETDB1 directly interacts with and stabilizes MCT1 via K473 tri-methylation.
• MCT1 K473 tri-methylation inhibits Tollip-mediated autophagic degradation.
• Elevated MCT1 K473 tri-methylation promotes tumor glycolysis and M2-like macrophage polarization in CRC, enhancing lactate shuttle.
• Clinical CRC samples show upregulated MCT1 K473 tri-methylation, correlating with tumor progression and poorer overall survival.

Conclusions:

• SETDB1-mediated MCT1 K473 tri-methylation is a novel regulatory mechanism for the lactate shuttle.
• This modification significantly contributes to colorectal cancer progression and metabolic reprogramming.
• MCT1 K473 methylation presents a potential prognostic biomarker and therapeutic target for colorectal cancer.